- Home
- TVGN vs SOPH Comparison
TVGN vs SOPH Comparison
Compare TVGN & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TVGN
- SOPH
- Stock Information
- Founded
- TVGN 2020
- SOPH 2011
- Country
- TVGN United States
- SOPH Switzerland
- Employees
- TVGN N/A
- SOPH N/A
- Industry
- TVGN Blank Checks
- SOPH Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TVGN Finance
- SOPH Health Care
- Exchange
- TVGN Nasdaq
- SOPH Nasdaq
- Market Cap
- TVGN 193.1M
- SOPH 206.6M
- IPO Year
- TVGN N/A
- SOPH 2021
- Fundamental
- Price
- TVGN $1.09
- SOPH $2.93
- Analyst Decision
- TVGN Strong Buy
- SOPH Strong Buy
- Analyst Count
- TVGN 1
- SOPH 2
- Target Price
- TVGN $10.00
- SOPH $6.50
- AVG Volume (30 Days)
- TVGN 1.6M
- SOPH 27.4K
- Earning Date
- TVGN 05-28-2025
- SOPH 05-06-2025
- Dividend Yield
- TVGN N/A
- SOPH N/A
- EPS Growth
- TVGN N/A
- SOPH N/A
- EPS
- TVGN N/A
- SOPH N/A
- Revenue
- TVGN N/A
- SOPH $67,173,000.00
- Revenue This Year
- TVGN N/A
- SOPH $14.86
- Revenue Next Year
- TVGN N/A
- SOPH $22.76
- P/E Ratio
- TVGN N/A
- SOPH N/A
- Revenue Growth
- TVGN N/A
- SOPH 4.66
- 52 Week Low
- TVGN $0.26
- SOPH $2.58
- 52 Week High
- TVGN $3.09
- SOPH $6.28
- Technical
- Relative Strength Index (RSI)
- TVGN 53.95
- SOPH 44.97
- Support Level
- TVGN $1.01
- SOPH $2.90
- Resistance Level
- TVGN $1.09
- SOPH $3.33
- Average True Range (ATR)
- TVGN 0.08
- SOPH 0.21
- MACD
- TVGN 0.02
- SOPH 0.00
- Stochastic Oscillator
- TVGN 81.02
- SOPH 21.78
About TVGN Tevogen Bio Holdings Inc. Common Stock
Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.
About SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.